Introduction
findings have just been reported in PKD2 disease [6 ] .
Despite these advances in the genetics of ADPKD, Autosomal dominant polycystic kidney disease the link between the mutated polycystins and the (ADPKD) is one of the most common monogenic cystogenesis process remains largely speculative. hereditary diseases (prevalence 15400-151000). It is Observations in PKD1 −/− mice indicate that characterized by the development of multiple cysts in polycystin-1 is required for renal tubular maturation both kidneys. These cysts grow slowly but steadily, [7] . On the basis that polycystin-1 can interact in vitro inducing a progressive renal insufficiency which leads, with polycystin-2, it is hypothesized that these proteins in about half of the patients, to end-stage renal failure are part of a complex signalling pathway involved in at a mean of 55 years. In Western Europe and North renal tubule maturation [8] . America, ADPKD is responsible for 4-10% of the patients requiring renal replacement therapy. Several extrarenal manifestations, including extrarenal cysts, Transepithelial fluid secretion in ADPKD cysts cardiac valvular abnormalities, and arterial aneurysms, contribute to the morbidity and mortality of the dis-While the genetics of ADPKD was under deep scrutiny, ease. Treatment of ADPKD is currently restricted to another line of research focused on the mechanisms the control of associated complications such as hyper-involved in intracystic fluid accumulation (for review, tension or infection [1] . see [9, 10] ). That interest was triggered by two simple Linkage to two loci named PKD1 and PKD2 was observations. First, careful morphological examination found in about 85 and 15% of the families affected of ADPKD kidneys had revealed that most cysts are with ADPKD respectively. A third locus is probably disconnected from their tubule of origin. Second, after involved in a small number of cases. The PKD1 and drainage, ADPKD cysts quickly fill again with liquid, PKD2 genes have been recently cloned [2, 3] , and the and this process is stimulated by adenylate cyclase encoded proteins actively investigated [4] . The product agonists. It was thus clear that intracystic fluid does of PKD1 ('polycystin-1') is a large (~460 kDa) protein not originate from glomerular filtrate but rather from including several transmembrane segments, a relatively a net, transepithelial fluid secretion. That is in striking short C-terminal intracellular domain, and a long contrast with the vast majority of fluid movements N-terminal extracellular portion containing domains through the nephron, which normally end with reabcharacteristic of cell-cell and cell-matrix interactions. sorption of more than 99% of the glomerular filtrate. The product of PKD2 ('polycystin-2') is a smaller
In most secretory epithelia, such as the trachea or (~110 kDa) integral plasma membrane protein that intestine, fluid secretion primarily depends of a transshows analogy with different Na+/Ca2+ channel sub-epithelial, cAMP-stimulated Cl− secretion. Several units. Its intracellular, C-terminal end includes a 29 lines of evidence, chiefly generated by the Grantham amino acid motif ( EF hand) involved in Ca2+ binding. group, have actually shown that this is also the case Recently, cyst-lining cells in PKD1 disease were found for ADPKD cyst-lining epithelia [10] . The key role of to be clonal and harbour a somatic mutation in the Cl− was demonstrated by monitoring in parallel curallele unaffected by germ-line mutation [5] . These rents and fluid secretion across intact cyst walls and characteristics suggest a 'two-hit' model for cystogen-monolayers of cultured ADPKD cyst cells. It was esis in PKD1 disease, in which the random occurrence shown that fluid secretion induced by cAMP-stimulatof the second hit might explain the inter-and intra-ing agonists (such as forskolin) (i) was accompanied cotransport) in the basolateral medium, or alternatively by Cl− channel inhibitors on the apical side of the preparation. Taken together, these results suggested that fluid secretion into ADPKD cysts is driven by a transepithelial Cl− secretion involving a basolateral cotransporter and an apical channel.
Molecular identification of chloride transporters
The analogy between the properties of ADPKD cystic epithelia and secretory epithelia further led to suggest that CFTR ('cystic fibrosis transmembrane conductance regulator'), the protein encoded by the CF gene [11], might be instrumental in the cAMP-stimulated Cl− secretion that occurs in ADPKD. Mutations in CF are responsible for cystic fibrosis, a frequent autosomal recessive disease characterized by defective hydration of exocrine secretions, the major clinical consequences of which are pancreatic insufficiency and recurrent airway infections [11] . Although highly expressed in the human fetal kidney, CFTR is downregulated in the adult kidney and there is no obvious renal phenotype in cystic fibrosis [12] . However, in ADPKD kidneys, CFTR is strongly expressed in the apical membrane area of epithelial cells lining about half of the cysts. Whole cell patch-clamp recording confirmed the occurrence of Cl− currents with the pharmacological profile of CFTR in ADPKD cyst cells [13] . The role of CFTR in ADPKD cells was also substantiated by the demonstration of a significant reduction of fluid secretion after long-term incubation of the monolayers with an antisense oligonucleotide against human CFTR [14] .
If the existence of an apical chloride channel accounted for Cl− extrusion, the mechanism of its entry at the basolateral side of ADPKD cyst cell had then to be clarified. The reduction of both luminal electronegativity and fluid secretion after the addition Figure 1A and B) . Transepithelial Cl− secretion is cyst fluid might result in the stimulation of protein G-coupled P2Y purinergic receptors, which in turn activate outwardly rectifying thus mediated by the basolateral BSC2 cotransporter chloride channels (ORCC ). The hypothesized result of these events and the apical CFTR channel operating in series. In is stimulation of Cl− secretion and exacerbation of fluid accumulaparallel with this movement of Cl−, Na+ accumulates tion. The molecular identity of the channel involved in apical ATP within the cyst lumen by electrical coupling. The nature release is debated; it has been suggested that CFTR, in addition to of the transepithelial Na+ pathway remains debated. Cl−, might also conduct ATP. (Modified from references [9, 18] .) Most data indicate that Na+ transfer is mainly paracellular; experimental evidence suggests that a Na+-K+-
ATPase located in the apical membrane may play a genes in polycystic kidney disease in animals and man.
A total genome scanning in the DBA/2-pcy/pcy mouse role; whether the expression of the sodium channel ENaC is preserved in ADPKD cyst-lining cells is still model of recessive PKD has led to the identification of two modifying loci named MOP1 and MOP2 [21]. unknown. Driven by the osmotic gradient, water crosses the epithelium and accumulates into the lumen, Three loci affecting the severity of PKD have also been described in another (kat2J/kat2J ) mouse model of either by a transcellular pathway involving aquaporins or by a paracellular pathway [17] . This model may recessive PKD [22] . In man, the simultaneous occurrence in the same family of PKD1 disease and cystic not be unique, given the diversity of tubule epithelia segments involved in cyst formation in ADPKD, as fibrosis provided the opportunity to look for a possible modifying effect of the CF gene. Renal involvement, illustrated by the heterogeneity of the expression of CFTR and other transporters in ADPKD cysts [9, 13] . as assessed by renal size and creatinine clearance was actually found to be less severe in two patients affected by both ADPKD and cystic fibrosis (CF mutations:
Regulation of cyst fluid accumulation
DF508/E60X and DF508/3849+10kb C>T ) than in relatives affected with ADPKD but heterozygous (DF508/N ) or unaffected (N/N ) by CF [23] , an obserNot unexpectedly for a secretory epithelium, Cl− secretion in ADPKD cyst cells appears to be regulated by vation which is in agreement with a protective effect of CF mutations in ADPKD. This finding should be cAMP, which stimulates protein kinase A-mediated phosphorylation and membrane expression of both confirmed in a larger population of patients affected by the two diseases and harbouring different CF muta-CFTR and BSC2 [11, 15] . Since the latter is the ratelimiting step of the transepithelial secretion, it is tempt-tions. It must be noted that the possibility of a modifier role of CF gene in ADPKD is also suggested by the ing to consider that abnormal stimulation of BSC2-induced for instance by modifications of the extracellu-lack of cystic phenotype in collecting duct cell lines derived from CF knock-out mice, as compared to lar matrix-might promote fluid secretion ( Figure 1B) .
Cyst fluid accumulation in ADPKD might also be numerous cysts formation observed with cells derived from wild-type mice [24] . regulated by autocrine and paracrine agonists. ATP (a small, negatively charged molecule) has been shown to Variants of other transporters involved in cyst expansion could also modulate ADPKD phenotype. For be released in the apical medium of cultured ADPKD cyst cells and has been detected in the micromolar example, Na+ transporters present in cystic epithelium and remaining normal tubular epithelium could regurange in a subset of cyst fluids harvested from ADPKD patients [18] . This ATP concentration is probably late cyst fluid accumulation and plasma volume expansion respectively. A modification of the latter might sufficient to stimulate purinergic receptors, a stimulation that exerts a potent secretagogue effect for fluid play a role in the development of hypertension, a probable determinant of progression of renal failure and Cl− in different epithelial cell types. Thus, intraluminal liberation of ATP (or its metabolites such as in ADPKD patients [1] . Other candidate genes are those coding for molecules involved in the regulation ADP, 5∞AMP or adenosine) in ADPKD renal cysts might enhance fluid secretion and therefore cyst expan-of fluid secretion (e.g. activation and polarization of the transporters, components of the phosphorylation sion ( Figure 1C ). One potential mechanism is the activation of outwardly rectifying chloride channels pathway), growth factors, and binding partners of polycystins. (ORCC ) by ATP, mediated by the G protein-coupled P2Y purinergic receptor. Of note, apical channels permeable to ATP remain to be identified, keeping in Conclusion, questions, and perspectives mind that cAMP-activated CFTR might itself be implicated [19] .
Whereas the sequence of events leading from mutations in PKD1 or PKD2 to cyst fluid accumulation remains
Towards modifier genes
largely speculative, some of the transporters involved in that process are now well characterized. These data support the hypothesis that Cl− secretion is involved The wide variability in the ADPKD phenotype has been emphasized [1] . Whereas interfamilial differences in the abnormal cyst fluid accumulation that characterizes ADPKD. On the other hand, important quesmay be accounted for by the nature of the mutation itself, as recently shown in PKD1 disease [20] , the tions-in particular the putative link between the genetic defect in ADPKD and hypersecretion-remain intrafamilial variability may be explained by the random occurrence of a second hit [5] . An alternative unsolved. Recent studies performed in C. elegans provided evidence that worm homologues of human PKD1 possibility is that molecular variants of the different transporters involved in intracystic fluid accumulation and PKD2 act together in a signal transduction pathway in sensory neurons [25] . Expression studies in exert a disease-modifying effect. For instance, variants associated with a decreased Cl− secretion might reduce Xenopus oocytes demonstrated that the polycystin-like protein (PCL), a human homologue of polycystin-2 intracystic fluid secretion, and thus slow cyst growth and delay the progression of renal failure.
that also contains an EF hand domain, is a cation channel regulated by Ca2+ [26 ] . Thus, PKD-related Preliminary data suggest the existence of modifier 10. Sullivan LP, Wallace DP, Grantham JJ. Epithelial transport in proteins might belong to a conserved signalling pathpolycystic kidney disease. Physiol Rev 1998; 78: way involving Ca2+ as a secondary messenger. 11. Welsh MJ, Tsui LC, Boat TF, Beaudet AL. Cystic fibrosis. In: Alterations in this pathway might impair cell matur- for the intra-familial variability in ADPKD phenotype.
